From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approved adjuvant nivolumab for melanoma

from Cancer Network via Modern Medicine

The U.S. Food and Drug Administration (FDA) has approved nivolumab (Opdivo) for the adjuvant treatment of patients with melanoma and involvement of lymph nodes or metastatic disease who have undergone complete resection. Nivolumab is the first programmed death 1 (PD-1) inhibitor to show superiority compared with the standard of care, ipilimumab, in this patient population. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063